first time, the Food and Drug Administration (FDA) permitted brand-specific DTC ads on TV without a "brief summary" of … Care Survey (NAMCS). We find that DTC advertising leads to a large increase in the number of outpatient drug visits, a … clarifying DTC ads if they do not prescribe the most advertised drug(s). Our results suggest that the effect of DTC advertising …

of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the … of new drug development, generic entry, and patent length and scope. Optimal policy calls for shorter but broader …

rebates and discounts they negotiate for drug insurance plans serving Medicare beneficiaries. This policy would significantly … change drug pricing and utilization and shift billions of dollars annually from patients and taxpayers to drug manufacturers …

dimensions of medication-related quality, namely the probability of inappropriate prescription drug use among United States … unobserved heterogeneity. We find a small, but measurable, negative price elasticity for inappropriate drug use with respect to …

We examine the impact of new medical information on drug safety on preventive health behavior. We exploit the release … spillover effects of drug safety on health behavior were entirely driven by the less educated. These findings suggest that …

any large pharmaceutical firms based in Finland, by the 1950s a similar partnership between medical experts and drug … national project and collaboration officially encouraged. After the Second World War the drug industry was no longer local, but … the close physician-drug industry relationship largely continued as before. There are indications today that both …

We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a … across- and within-drug heterogeneity. We focus on six drug markets that that were part of the expanded initial complaint and …